The next study has also documented the suppressive impact of EA on cell viability, in addition to its capacity to arrest the cell cycle at the G1 phase and induce the upregulation of protein expression for both p53 and p21 in two distinct ovarian carcinoma cells (ES-2 and PA-1) [56]. The gene discussed is TP53; the disease is ovarian carcinoma.